AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $988,800 | -37.5% | 96,000 | 0.0% | 0.50% | -32.1% |
| Q2 2023 | $1,582,080 | +79.9% | 96,000 | 0.0% | 0.74% | +80.0% |
| Q1 2023 | $879,360 | +27.9% | 96,000 | 0.0% | 0.41% | +29.4% |
| Q4 2022 | $687,360 | +43.2% | 96,000 | 0.0% | 0.32% | +26.4% |
| Q3 2022 | $480,000 | +105.1% | 96,000 | 0.0% | 0.25% | +129.4% |
| Q2 2022 | $234,000 | -43.8% | 96,000 | +57.4% | 0.11% | -37.7% |
| Q1 2022 | $416,000 | -15.4% | 61,000 | 0.0% | 0.18% | -13.4% |
| Q4 2021 | $492,000 | -17.6% | 61,000 | 0.0% | 0.20% | -24.9% |
| Q3 2021 | $597,000 | +45.6% | 61,000 | 0.0% | 0.27% | +48.6% |
| Q2 2021 | $410,000 | -25.6% | 61,000 | 0.0% | 0.18% | -28.2% |
| Q1 2021 | $551,000 | +35.4% | 61,000 | 0.0% | 0.25% | +22.9% |
| Q4 2020 | $407,000 | +32.6% | 61,000 | 0.0% | 0.20% | +24.2% |
| Q3 2020 | $307,000 | – | 61,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |